Prices coming to television The whole purpose of direct-to-consumer (DTC) advertising is to get patients to go to their doctors and inquire about a brand-name drug, which is why most ads’ “action item” is telling you to “talk to your doctor.” DTC is also a practice that’s banned in every country except for the United […]
Current laws have tied the hands of our state medical programs by denying them the right to negotiate medication prices with pharmaceutical manufacturers. We tell them that they will have to take what they can get and deal with the price gouging. So in turn, the state programs have to constantly judge which brand is […]
At a time when we at Kaiser Permanente are working hard to find efficiencies that bring down costs, our pharmaceutical costs keep going up. In the last two years, prescription drug prices for Kaiser Permanente in Washington have increased by $70 million. The situation is even worse for specialty drugs. These higher-cost, hard-to-manufacture, or hard-to-handle/administer […]
During President Trump’s State of the Union speech, he spoke about the urgent need to lower prescription drug prices. He talked about global freeloading and the injustice of Americans paying more for drugs that are made here than foreign countries do. He discussed the need for price transparency, where drug manufacturers reveal their list prices […]
In response to the problem of rising list prices for drugs, elected officials continue to propose counterproductive reforms. Whether it is importing drugs from Canada or indexing U.S. drug prices to the prices charged in other countries, these policies will make the current bad situation worse because they fail to understand the disincentives that are […]
From dinner tables to the halls of Congress, the price of prescription drugs has recently dominated conversations across the country. Last year, President Trump unveiled the American Patients First blueprint to reduce the costs of prescription drugs and limit out-of-pocket costs for American consumers. In an effort to address drug costs, President Trump and Health and Human […]
Drug manufacturers Teva Pharmaceutical and Prinston Pharmaceutical were recently forced to recall the important drug valsartan after the Food and Drug Administration determined that the blood pressure medication might contain carcinogens. Drug manufacturer Alembic Pharmaceuticals was not affected by the recall, as its own version of the medication was not found to contain the same […]
Johnson & Johnson appears to have listened to President Donald Trump’s State of the Union Address Tuesday. Trump, in a portion of his speech devoted to health care, called on pharmaceutical companies to reveal “real prices” – presumably a reference to an administration proposal that would require drugmakers to show the full sticker price, or […]
The ACT Liberals committed to the fuel watch scheme last month after a series of reports by the Canberra Times on the price gouging that has been a feature of life here for decades. Those reports noted fuel prices at one and two bowser service stations within 40 and 50 minutes drive of the ACT […]
Senator Bernie Sanders is taking on a large pharmaceuticals company and demanding to know why a life-saving drug for a rare condition has seen its price increase by hundreds of thousands of dollars. Sanders, who has made the problem of drug pricing a major focus of his time in the Senate, released a letter dated February 4 and […]
This Week in Pricing > 2/23/19
TWIP is a digest of pricing focused news, thought leadership, events, jobs, training and certification resources for pricing professionals. This Edition is brought to you by: PriceBeam The struggle is real for B2B and B2C Pricing, Marketing, and Finance team leaders to capture fresh, reliable, and actionable Pricing Intelligence data to be able to effectively optimize all prices for all market segments […]
PND is a digest of pricing focused news, thought leadership, events, jobs, training and certification resources for pricing professionals. This Edition is brought to you by: Professional Pricing Society Currently, PPS produces three major annual pricing conferences in Europe and North America. Each conference also houses a technology hall where sponsors display the latest in Pricing […]
Lyft’s ‘Shared Saver’ Feature Has Riders Pay Less But Walk More | Fortune
Lyft launched a new Shared Saver feature Thursday that banks on the assumption that riders are willing to walk a couple blocks to save a couple bucks. Promising to provide the app’s lowest prices, unaffected by surge pricing, Lyft wrote on its blog that Shared Saver gives riders a “pickup spot that’s a quick walk […]
Pricer’s Points: Why Does Bottled Water Cost Significantly More than Tap Water? | Elena Galli
More or less one month ago I was at the airport, heading back to Barcelona after having spent some days in my hometown, Ferrara, a little city in Northern Italy. I was very thirsty so I headed to the first bar I saw and ended up spending an excruciatingly expensive price for my half a […]
Remember MoviePass? It was just delisted | The Chestnut Post
The movie subscription service on Thursday announced a new, complicated pricing structure that is dependent on geography and the kind of movies customers want to watch. Starting in January, MoviePass will offer three plans that members can choose from. The first, called “Select,” starts at $10 a month and will allow subscribers to see three […]
Connect
Follow via RSS feed or on the following social media platforms.